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Abstract
To understand the interplay of residual structures and conformational fluctuations in the interaction of intrinsically
disordered proteins (IDPs), we first combined implicit solvent and replica exchange sampling to calculate atomistic
disordered ensembles of the nuclear co-activator binding domain (NCBD) of transcription coactivator CBP and the activation
domain of the p160 steroid receptor coactivator ACTR. The calculated ensembles are in quantitative agreement with NMR-
derived residue helicity and recapitulate the experimental observation that, while free ACTR largely lacks residual secondary
structures, free NCBD is a molten globule with a helical content similar to that in the folded complex. Detailed
conformational analysis reveals that free NCBD has an inherent ability to substantially sample all the helix configurations
that have been previously observed either unbound or in complexes. Intriguingly, further high-temperature unbinding and
unfolding simulations in implicit and explicit solvents emphasize the importance of conformational fluctuations in
synergistic folding of NCBD with ACTR. A balance between preformed elements and conformational fluctuations appears
necessary to allow NCBD to interact with different targets and fold into alternative conformations. Together with previous
topology-based modeling and existing experimental data, the current simulations strongly support an ‘‘extended
conformational selection’’ synergistic folding mechanism that involves a key intermediate state stabilized by interaction
between the C-terminal helices of NCBD and ACTR. In addition, the atomistic simulations reveal the role of long-range as
well as short-range electrostatic interactions in cooperating with readily fluctuating residual structures, which might
enhance the encounter rate and promote efficient folding upon encounter for facile binding and folding interactions of
IDPs. Thus, the current study not only provides a consistent mechanistic understanding of the NCBD/ACTR interaction, but
also helps establish a multi-scale molecular modeling framework for understanding the structure, interaction, and
regulation of IDPs in general.
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Introduction
It is now widely recognized that many functional proteins lack
stable tertiary structures under physiological conditions [1–5].
Importantly, such intrinsically disordered proteins (IDPs) are
highly prevalent in proteomes [6], play crucial roles in cellular
areas such as signaling and regulation [7,8], and are often
associated with human diseases such as cancers [9–11]. The
concept that intrinsic disorder can confer functional advantages
has been discussed extensively [12–16]. For example, the
disordered nature of IDPs could offer several unique benefits for
signaling and regulation, including high specificity/low affinity
binding, inducibility by posttranslational modifications, and
structural plasticity for binding multiple partners. The last
property appears to be particularly advantageous, and could
support one-to-many and many-to-one signaling [16,17]. None-
theless, the physical basis of these proposed phenomena remains
largely elusive. Specifically, how IDP recognition and regulation
are supported by the interplay of residual structures, conforma-
tional fluctuations and other physical properties as encoded in the
peptide sequence is poorly understood.
The current limit in mechanistic understanding of how intrinsic
disorder supports function might be attributed to two key
challenges in characterizing IDPs. These challenges are broadly
shared by mechanistic studies of protein folding, misfolding, and
aggregation in general [18–21]. The first one is related to the
difficulty in deriving detailed structural information of the
disordered unbound states [22–25]. In general, only ensemble-
averaged properties can be measured for disordered proteins
except with single-molecule techniques (which have their own
limitations in spatial resolution, labeling need, and protein size
[26–28]). Recovering the underlying structural heterogeneity using
averaged properties is a severely underdetermined problem [29–
33]. It is generally not feasible to construct a unique disordered
structure ensemble that is consistent with the available data. This
fundamental limitation leads to significant ambiguity in the
current knowledge of the conformational nature of unbound
IDPs. The second challenge is to further clarify the functional roles
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of any putative conformational sub-states or other properties of an
IDP in its recognition and regulation (i.e., ‘‘function’’). In
particular, whereas some IDPs remain disordered in complexes
[34,35], many fold into stable structures upon binding to specific
targets [36]. The roles of intrinsic disorder vs. residual structures in
such coupled binding and folding interactions have been under
much debate [36]. On one hand, residual structures have been
observed frequently in unbound IDPs, and intriguingly, such
residual structures often resemble those in the folded complexes
[37–41]. These observations have led to an attractive hypothesis
that preformed structural elements might provide initial binding
sites to facilitate efficient recognition (i.e., conformational
selection-like mechanisms) [12,37]. On the other hand, evidence
has accumulated in recent years, from computation as well as
experimentation, to support a central role of nonspecific binding
and emphasize the importance of disordered nature itself in
promoting facile IDP recognition [41–51]. In fact, all published
studies that extend beyond examining the unbound states alone
have suggested induced folding-like mechanisms, at least at the
baseline level.
Precisely how the disordered nature contributes to binding,
however, is less clear. One proposal is that nonspecific binding of
unstructured and presumably more extended conformations can
increase the capture radii to enhance the binding kinetics [52,53];
however, such ‘‘fly-casting’’ effects is small with a theoretical
maximum of ,1.6-fold acceleration. Recent studies have shown
that unbound IDPs tend to be much more compact than
previously assumed [54–57], further reducing the proposed fly-
casting affects. In addition, the rate-enhancing affect due to
increased size is likely offset by slower diffusion [58]. Alternatively,
the unbound state of IDPs is presumed heterogeneous and strongly
fluctuating. More specifically, conformational sub-states in the
unbound IDPs should be marginally stable and separated by small
free energy barriers (e.g., a few kcal/mol or less). These
conformational fluctuations could contribute to efficient IDP
recognition by allowing the peptide to fold rapidly upon
(nonspecific) binding [50,58], which is required for achieving the
diffusion-controlled maximum binding rate (otherwise folding
becomes rate-limiting) [59]. It should be noted that cellular events
frequently modify the folding of IDPs to modulate their activities,
such as through phosphorylations or by binding of other proteins
[60]. Therefore, in contrast to globular proteins where folding
often serves only to achieve the native structures, folding and
unfolding appears to be direct and inherent aspects of IDP
function. This underpins the importance and biological relevance
of obtaining a mechanistic understanding of binding-induced
folding of IDPs beyond a subject of theoretical curiosity.
The challenge in detailed characterization of IDPs represents a
unique opportunity for molecular modeling to make critical
contributions [5]. In particular, atomistic simulations could
provide the ultimate level of detail necessary for understanding
the structure and interaction of IDPs. At the same time, the
dynamic and heterogeneous nature of IDPs also pushes the limits
of both the force field accuracy and conformational sampling
capability. So-called implicit solvent is arguably an optimal choice
for de novo simulations of IDPs because of its necessary balance of
accuracy and speed [61–64]. The basic idea of implicit solvent is to
capture the mean influence of water by direct estimation of the
solvation free energy, therefore reducing the system size about 10-
fold. Important advances have been made to greatly improve the
efficiency and achievable accuracy of implicit solvent, such as via
the popular generalized Born (GB) theory [64]. With reduced
system size, implicit solvent is also particularly suitable for replica
exchange (REX) simulations [65–67], an enhanced sampling
technique that has proven highly effective in sampling protein
conformational equilibria [68]. Importantly, improved efficiency
with implicit solvent also allows careful optimization to suppress
certain systematic biases that have plagued explicit solvent
approaches [69,70]. For example, we have previously optimized
the generalized Born with smooth switching (GBSW) model
[71,72] together with the underlying CHARMM22/CMAP
protein force field [73–76]. The resulting GBSW protein force
field not only recapitulates the structures and stabilities of helical
and b-hairpin model peptides with a wide range of stabilities
[77,78], but also allows calculation of the conformational
equilibria of small proteins under stabilizing and destabilizing
conditions [79–81]. Although inherent and methodological
limitations remain in implicit solvent [82], initial applications of
implicit solvent to modeling small IDPs have been reasonably
successful [41,46,55,83–86], substantiating the notion that it is a
viable approach for atomistic simulations of IDPs.
The current work focuses on the nuclear-receptor co-activator
binding domain (NCBD) of the transcription coactivator CREB-
binding protein (CBP) and its interaction with the p160 steroid
receptor co-activator ACTR. CBP and its paralogue p300 are
general transcriptional coactivators that play critical roles in
transcriptional regulation and participate in cell cycle control,
differentiation, transformation, and apoptosis [87,88]. The NCBD
domain (residues 2059–2117 in mouse CBP) is also known as
interferon regulatory factor (IRF) binding domain (iBID) or the
SRC1 interaction domain (SID). It mediates the interaction of
CBP with a number of important proteins, including steroid
receptor coactivators, p53 and IRFs [2,89]. The interaction of
CBP with p160 coactivators in particular is important for
recruitment of CBP/p300 to transmit the hormonal signal to the
transcription machinery [90]. Besides the biological and medical
significance, the NCBD/ACTR interaction also offers unique
opportunities for understanding the molecular principles of IDP
recognition. Both NCBD and the activation domain of ACTR that
it interacts with (residues 1018–1088 in human ACTR; hereafter
referred to as ACTR) are IDPs. Their interaction is an example of
the ‘‘synergistic folding’’ mechanism [91] (the other known
example also involves NCBD, but with the p53 transactivation
domain, TAD [92]). In addition, four folded structures of NCBD
Author Summary
Intrinsically disordered proteins (IDPs) are now widely
recognized to play fundamental roles in biology and to be
frequently associated with human diseases. Although the
potential advantages of intrinsic disorder in cellular
signaling and regulation have been widely discussed, the
physical basis for these proposed phenomena remains
sketchy at best. An integration of multi-scale molecular
modeling and experimental characterization is necessary
to uncover the molecular principles that govern the
structure, interaction, and regulation of IDPs. In this work,
we characterize the conformational properties of two IDPs
involved in transcription regulation at the atomistic level
and further examine the roles of these properties in their
coupled binding and folding interactions. Our simulations
suggest interplay among residual structures, conforma-
tional fluctuations, and electrostatic interactions that
allows efficient synergistic folding of these two IDPs. In
particular, we propose that electrostatic interactions might
play an important role in facilitating rapid folding and
binding recognition of IDPs, by enhancing the encounter
rate and promoting efficient folding upon encounter.
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have been solved in complex with various protein targets besides
ACTR [91–94]. In these complexes, NCBD adopts two distinct
tertiary folds that involve three similar helices, represented by the
NCBD/ACTR and NCBD/IRF3 complexes (see Figure 1).
Therefore, NCBD represents one of the few experimentally
validated examples of structural plasticity, which is believed to be a
key functional advantage of intrinsic disorder [16].
Interestingly, although free ACTR is largely devoid of residual
structures, free NCBD contains one the highest levels of residual
structures with folded-like helical content and molten globule
characteristics [95,96]. In addition, even though nuclear magnetic
resonance (NMR) relaxation analysis has established that free
NCBD is highly dynamic on picosecond (ps) to nanosecond (ns)
timescales [96], it appears to have a strong tendency to adopt
marginally stable tertiary folds, allowing two NMR structures of
the unbound state determined to date [40,89]. These structures
are presumably obtained by stabilizing various conformational
sub-states under specific solution conditions. Particularly intriguing
is that the latest NMR structure of free NCBD turns out to be
similar to the folded conformation observed when bound to
ACTR [40]. Although such pre-existence of folded-like confor-
mations should be considered only as a necessary but insufficient
condition for conformational selection-like mechanisms, the
unusually high level of residual structures of NCBD strongly
suggests a functional role of pre-folding in its coupled binding and
folding interactions. In this work, we first exploit implicit solvent-
based atomistic simulations and REX enhanced sampling to
characterize the conformational properties of free NCBD and
ACTR. The roles of preformed structures vs. conformational
fluctuation in the NCBD/ACTR interaction are then directly
probed using high-temperature unfolding and unbinding simula-
tions in both implicit and explicit solvents. Combined with our
recent coarse-grained simulations and existing experimental data,
we aim to obtain a detailed mechanistic picture of how residual
structures, conformational fluctuations, and electrostatic interac-
tions contribute to efficient synergistic folding of NCBD and ACTR.
Results
Convergence and validation of the disordered structure
ensembles
De novo calculation of the disordered ensembles for IDPs is
challenging [5], especially for NCBD that is both of moderate size
and apparently with a complex, solution condition-sensitive
conformational equilibrium. Our previous works have suggested
that implicit solvent coupled with REX enhanced sampling could
generate reasonably accurate disordered ensembles for small IDPs,
including a 28-residue segment of the kinase inducible domain
(KID) of transcription factor CREB [55]. In Figure S1, we first test
the convergence of the calculated disordered ensembles by
examining the dependence of residue helicity on REX simulation
time and by comparing results from independent simulations
initiated from dramatically different conformations (folding vs.
control; see Methods). The sequences of both domains are
provided in Methods. Free ACTR appears to be highly disordered
with marginal residual helicity. The calculated residual helicity
profiles from the control and folding runs converge to similar ones
(data not shown). For NCBD, while the time evolution of the
calculated residual helicity appears to stabilize over the course of
100 ns in either the control or folding REX simulation, the final
profiles from these two independent calculations differ substan-
tially, suggesting that the actual convergence is rather limited.
Nonetheless, both the folding and control simulations clearly
suggest significant residual helicity in all three helical segments that
become stably folded upon binding to various specific targets.
Detailed analysis of the conformational ensemble (see below)
demonstrates that free NCBD is compact and contains substantial
tertiary contacts. These conformational properties of NCBD,
coupled with the larger size, contribute to the difficulty of
achieving better convergence using the REX/GB protocol. In
addition, the current surface area-based treatment of nonpolar
solvation can over-stabilize non-specific collapsed states [82,97].
This problem further limits the ability to sufficiently sample
Figure 1. Two representative folded conformations of NCBD. A) NMR structure of the NCBD/ACTR complex (PDB: 1kbh [91], model 1). Both
NCBD and ACTR contain 3 helical structure segments, labeled as Ca1 (blue), Ca2 (red) and Ca3 (magenta) in NCBD and Aa1, Aa2 and Aa3 in ACTR. See
Methods for specific residue ranges of these helical segments. Several key structural features are also marked, including the poly-Q loop (yellow)
linking Ca1 and Ca2, a buried salt-bridge between NCBD R2105 and ACTR D1068, and several key charged residues adjacent to this buried salt-bridge.
B) X-ray crystal structure of the NCBD/IRF3 complex (PDB: 1zoq [94]). C) Overlay of the folded structures of NCBD in complex with IRF3 (yellow) and
ACTR (green). Only the structured segment (residues 2066–2112) is shown, and the two structures are aligned using the backbone atoms of Ca2.
doi:10.1371/journal.pcbi.1002353.g001
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accessible tertiary organizations of free NCBD and their inter-
conversions, which is required for achieving good convergence.
Given the limited convergence achieved in the REX simulations
of free NCBD and apparent difficulties in substantially improving
the level of convergence, we focus on semi-quantitative or
qualitative analysis of the conformational properties of NCBD.
That is, although significant conformational sub-states sampled by
REX may be genuine, the relative stability (population) is not
likely to be reliable. Considering that NCBD is experimentally
known to be highly helical, the folding simulations (initiated with a
fully extended conformation) should take longer to converge, and
the disordered ensemble calculated from the control simulation is
likely more realistic. Therefore, all the subsequent analysis is based
on the ensemble of conformations sampled during the last 60 ns of
the 100 ns control REX simulation. In Figure 2, we compare the
residue helicity of NCBD and ACTR in the free and bound states.
The results appear to be fully consistent with the previous NMR
secondary chemical shift analysis (Figure 2 of Ref. [96]), showing
that all three NCBD helices are largely formed in the unbound
state and ACTR is largely free of residual helices. Interestingly, the
poly-Q segment of NCBD (residues 2082–2086), although
disordered in the NCBD/ACTR complex, is largely helical in
the unbound state and extends Ca2. This is fully consistent in the
NMR chemical shift analysis [96]. Recent sequence correlation
analysis has revealed a link between sequence order and binding
promiscuity [98,99]. One might expect that the length of the poly-
Q stretch might affect conformational flexibility, and furthermore,
the ability to interact with diverse targets. We also have analyzed
the ensemble distribution of the radius of gyration of free NCBD.
The results, shown in Figure S2A, confirm that free NCBD is
highly compact. Despite a clear lack of convergence, the control
and folding simulations appear to sample a set of conformation
sub-states with similar characteristic sizes. Direct comparison of
the calculated size profiles to one derived from a recent small-
angle X-ray scattering (SAXS) study [40] is complicated by the
different constructs used and uncertainty in proper inclusion of the
solvation shell for a heterogeneous ensemble. Nonetheless, one can
estimate that including the disordered N- and C-terminal tails (13
residues total) truncated in the current simulations would increase
the radius by 2–3 A˚, and that the solvation shell may add another
2–3 A˚ (estimated by comparing results from HydroPro [100] and
CHARMM). These corrections together bring the calculated
radius of the gyration profile close to the SAXS-derived profile
that centers around 15.2 A˚ under ‘‘native-like’’ conditions [40].
Apparent agreement between NMR and SAXS on these
ensemble-averaged properties is not sufficient to validate the
reliability of the simulations, but it suggests that the simulated
ensemble may offer a qualitative or even semi-quantitative
characterization of the conformational properties of free NCBD.
Folded-like conformations in the unbound state of NCBD
Because all three NCBD helices are largely formed in the
unbound state, the conformational fluctuation of free NCBD
mainly involves tertiary packing of these helices. For example, as
shown in Figure 1, when aligned using the central helix Ca2, the
two representative folded conformations of NCBD differ mainly in
the orientation of Ca1 and slightly less so in that of Ca3.
Therefore, all conformations of the calculated ensemble first re-
oriented by aligning Ca2 (to the 2z axis) before the orientations of
Ca1 and Ca3 were calculated. Note such analysis also provides an
effective description of the tertiary packing even when one or more
of the three NCBD segments are not in helical states. The results,
shown in Figure 3, illustrate that NCBD is strongly fluctuating and
samples a large number of helix configurations, as expected for a
molten globule. Intriguingly, free NCBD appears to substantially
sample all three distinct conformations that have been observed
experimentally so far, either in complexes or in isolation. These
folds are represented by PDB structures 1kbh, 1zoq, and 1jjs,
respectively. The Ca1 orientation of 1kbh and Ca3 orientation of
1jjs appear to be least sampled. Nonetheless, conformational sub-
states exist with similar orientations, as marked by arrows in panels
c) and d) of Figures 3. Specifically, for 1kbh-like Ca1 orientation,
the adjacent sub-state contains more parallel (with smaller helix
cross angles), and thus tighter, packing of Ca1 with Ca2, but with a
helix interface similar to that of 1kbh. Further structural analysis
(see the following paragraph) suggests that such tighter packing is
likely a result of helix formation in the poly-Q segment (e.g., see
Figure 2), which shortens the Ca1-Ca2 loop and promotes tighter
packing.
Clustering analysis was performed to further analyze the
structural properties of the major conformational sub-states of
free NCBD. The average structures of the six most populated
Figure 2. Calculated residue helicity of NCBD and ACTR in the free and bound states. Results for the bound state were calculated from a
100 ns control simulation of the complex (see Methods), and those for the free peptides were calculated based the conformationals sampled at 305 K
during the last 60 ns of the control REX simulations.
doi:10.1371/journal.pcbi.1002353.g002
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clusters identified using K-means clustering with a 3.0 A˚ radius are
shown in Figure 4. Helix configurations for all members of these
clusters are shown in Figure S3. Interestingly, even though one of
the clusters (Figure 4D) is similar to the fold observed in 1kbh,
most clusters are different from either 1zoq or 1kbh on the whole
domain level, as suggested by the large RMSD values. Therefore,
even though both individual Ca1-Ca2 and Ca2-Ca3 helix pairs
sample all three distinct PDB folds, these folded-like configurations
of individual helix pair generally do not occur at the same time.
Notably, the folded conformations of NCBD in 1kbh and 1zoq
have relatively similar Ca2-Ca3 helix packing (see Figure 1C). The
packing of Ca2 and Ca3 also appears to be more restricted in free
NCBD compared to that of Ca1 and Ca2 (e.g., as indicated by a
larger ‘‘inhibited’’ red area in Figure 3D compared to Figure 3C).
NCBD has a strong inherent propensity to adopt Ca2-Ca3
configurations analogous to those in 1kbh and 1zoq. Such
persistent folded-like conformations of free NCBD could contrib-
ute to recruitment of specific targets such as ACTR and IRF3,
allowing NCBD to adopt different final structures by docking the
more flexibly linked Ca1 into different positions. Another
interesting observation is that the poly-Q segment appears to be
capable of readily switching between helical and coil states. Such
conformational fluctuations could allow NCBD to adapt to
different substrates, extending the Ca2 helix when bound with
IRF3 but becoming more disordered when in complex with
ACTR (see Figure 1).
Induced folding-like mechanism on the baseline level
Although the REX simulations provide intriguing insights into
the possible residual structures of free NCBD, how these
Figure 3. Orientations of NCBD Ca1 and Ca3 with respect to Ca2 in the unbound state. All conformations sampled at 305 K during the last
60 ns of the control REX simulation were first aligned using the backbone atoms of Ca2, and then reoriented such that Ca2 was aligned with 2z axis.
The orientations as observed in three distinct folds of NCBD, represented by PDB 1kbh, 1zoq, and 1jj (also see Figure 1), are marked with ‘‘+’’, ‘‘6’’, and
‘‘w’’, respectively. Note that different colors for the same symbol may be used in different panels for clarity. In panels c) and d), Q and h are the
inclination and azimuth angles of the spherical coordinate system. Note that the PMFs were computed using sin(h) instead of h itself as an order
parameter to remove the Jacobian entropy contribution. The range shown corresponds to h= 0 (top) to p (bottom). Contours are drawn at every kT
up to 7 kT, with k being the Boltzmann factor.
doi:10.1371/journal.pcbi.1002353.g003
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conformational properties contribute to synergistic folding of
NCBD with ACTR is not obvious based on these equilibrium
simulations alone. For this, one could calculate the coupled
binding and folding free energy surfaces [41,51] or transition paths
[46] to more directly clarify the recognition mechanism and probe
the roles of residual structures vs. pre-folding in specific finding.
However, given the moderate size and relatively complex
topology, such calculations can be extremely demanding using
an atomistic physics-based force field for the NCBD/ACTR
complex. Instead, temperature-induced unfolding and unbinding
simulations may be used to effectively infer the molecular processes
of coupled binding and folding. A key assumption is that binding/
folding is largely a reverse of unbinding/unfolding. An important
concern is that the transition states or the most probable transition
paths might depend on temperature [101]. Nonetheless, high-
temperature unfolding simulations have so far proven quite
successful for studying folding and interaction of many proteins,
including IDPs [44,102–104].
A 100 ns equilibrium simulation of the complex was first
performed at 300 K, which confirms that the native fold (model 1
of PDB:1kbh) is very stable in the GBSW/MS2 implicit solvent
(see Figure S4). Subsequent pilot simulations suggest 475 K to be
optimal for simulating unbinding and unfolding of the NCBD/
ACTR complex in GBSW/MS2 (e.g., see Figure S5). In Figure 5,
we compare the time evolution of various fractions of native
contacts computed from 50 independent unfolding simulations at
475 K. The fraction of native intermolecular interactions (Qinter) is
used to describe binding, and the fraction of native tertiary
intramolecular interactions (QNCBD) is used for folding of NCBD.
As shown in Figure S6, ACTR is completely devoid of any inter-
helix tertiary contacts in the NCBD/ACTR complex. Because
ACTR is largely free of residual structures in the unbound state,
the overall helicity (aACTR) is used to effectively monitor (binding-
induced) folding of ACTR. On the baseline level, all unfolding and
unbinding kinetics appear to be reasonably well represented by
single exponential functions. The fitted kinetic data is summarized
in Table 1. The secondary (helix) unfolding of NCBD is predicted
to be the slowest process (aNCBD; green traces in Figure 5), which is
expected given the high level of residual structures in unbound
NCBD; however, both the ACTR (helix) and NCBD tertiary
unfolding appear to be significantly faster than unbinding. This
result suggests that binding occurs prior to the folding of both
ACTR and NCBD; that is, both ACTR and NCBD follow
induced-folding-like mechanisms on the baseline level in the
GBSW/MS2 implicit solvent. Considering the apparent tendency
of NCBD to pre-fold (see above), this result is somewhat surprising,
but it highlights the importance of conformational fluctuations and
nonspecific binding in specific recognition of IDPs, even for IDPs
with significant residual structures like NCBD. Significant
heterogeneity is apparent in the unfolding/unbinding pathways
of NCBD/ACTR and is partially reflected in substantial
ruggedness that remains in the curves shown in Figure 5 (e.g.,
Figure 4. Averaged structures of the six most populated clusters of free NCBD. These clusters are identified based on the conformations
sampled at 305 K during the last 60 ns of the 100 ns REX control simulation. All structures were aligned by minimizing the backbone RMSD of Ca2
(the red segments) and visualized in the same view. The numbers below each structure are the population of the cluster and backbone RMSD values
from the folded conformations in 1kbh and 1zoq (see Figure 1). The protein is colored in the same fashion as in Figure 1a–b.
doi:10.1371/journal.pcbi.1002353.g004
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compared with a previous explicit solvent unfolding simulation of
the p53-MDM2 complex, where 10 10-ns simulations at 498 K
were sufficient to yield much smoother curves [103]). The complex
fully disassociates within 10 ns in only 6 out of the 50 independent
runs. In examining the unbinding/unfolding characteristics at a
lower temperature of 450 K (see Figure S7), we found the
heterogeneity of unfolding/unbinding pathways to be even more
evident. In addition, the complex appears trapped in some
intermediate states and does not fully unfold/unbind even after
20 ns. Nonetheless, unfolding of either ACTR or NCBD appears
to lag behind unbinding, which is consistent with the induced-
folding baseline mechanisms predicted at 475 K.
Binding and folding intermediates involving the NCBD
and ACTR C-terminal segments
Indications are that binding-induced folding of NCBD and
ACTR is not simply 2-state-like. For example, decay of QNCBD
and aACTR appears to pause at ,2 ns (red and blue traces in
Figure 5), which could suggest a common intermediate state where
ACTR and NCBD are partially bound and folded. The decay
curves are too noisy (partially due to underlying heterogeneity) for
reliable kinetic fitting using double exponential functions.
Therefore, we constructed (pseudo) unbinding and unfolding free
energy surfaces based on statistics collected from the first 5 ns of
the unfolding simulations. Note that the system is not at
equilibrium during this time frame, so the resulting free energy
profiles are not equilibrated (and thus strongly dependent on initial
conditions). Nonetheless, the profiles provide qualitative approx-
imations of the true free energy surfaces [105]. As shown in
Figure 6A, an intermediate state is evident at Qinter,0.25 and
QNCBD,0.15. Interestingly, a similar key intermediate state also
has been predicted in our recent topology-based modeling of the
NCBD/ACTR complex [50]. A strong resemblance between the
free energy surface is shown in Figure 6A and the result derived
from topology-based modeling (Figure 5A of reference [50]). Both
the atomistic simulations (see further analysis detailed in the
following paragraph) and topology-based modeling predict that
the intermediate state mainly involves the C-terminal segments of
NCBD and ACTR. Such a prediction appears highly consistent
with a recent H/D exchange mass spectrometry (H/D-MS) study
[106], where peptide segments within the C-terminal regions of
both NCBD and ACTR were found to have much larger
protection factors compared with those mapped into other folded
regions of the complex.
In Figure 7, we further examined the binding kinetics of
individual NCBD and ACTR helices. The kinetic data derived
from fitting to single exponential functions is summarized in
Table 1. The analysis shows that Aa3 and Ca3 unbind with the
largest half times, t= 2.93 ns and 2.20 ns, respectively, which are
greater than that of the overall intermolecular interaction
formation (t= 1.61 ns). This result indicates that binding is mainly
initiated by the C-terminal helices. In contrast, the first helices of
NCBD and ACTR unbind much faster then the second and third
helices. In fact, unbinding of Aa1 and Ca1 occurs even faster than
folding of either NCBD or ACTR (as described by QNCBD and
aACTR, see Table 1). These kinetic rates are consistent with a
multi-stage synergistic folding process, where NCBD and ACTR
first bind rapidly through the C-terminal segments, forming
intermediates that are mainly stabilized by native-like interactions
between a2 and a3 helices. This first step appears to be highly
cooperative (e.g., see Figure 6A), although indications are that
both induced folding and conformational selection might contrib-
ute [50]. Interestingly, the transition between the intermediate and
bound states appears largely conformational selection-like where
NCBD and ACTR folding precedes Aa1 and Ca1 binding.
Formation of the partially folded core appears to facilitate the rest
of NCBD to fold into native-like conformations, allowing Ca1 and
Aa1 to rapidly form native intermolecular interactions en route to
the fully folded bound state. Taken together, even though the
synergistic folding of NCBD and ACTR follows an induced
folding-like baseline mechanism (where binding precedes folding
on the overall level), detailed analysis reveals multiple stages of
induced folding and conformational selection. Such a mechanism
closely resembles an ‘‘extended conformational selection’’ recently
proposed by Csermely et al. [107,108] and is remarkably
consistent with our recent topology-based modeling of the
NCBD/ACTR complex [50].
Table 1. Unfolding and unbinding kinetic constants at 475 K.
t (ns) A B R2
Qinter 1.61 0.23 0.17 0.94
Ca1 0.26 0.37 0.00 0.97
Ca2 1.52 0.25 0.034 0.84
Ca3 2.20 0.24 0.23 0.94
Aa1 0.80 0.34 0.037 0.94
Aa2 1.39 0.26 0.26 0.86
Aa3 2.93 0.32 0.30 0.86
QNCBD 0.94 0.27 0.055 0.90
aNCBD 1.76 0.31 0.15 0.96
aACTR 1.38 0.20 0.13 0.89
All curves were fitted by single exponentials A exp (2t/t)+B. R is the correlation
coefficient of fitting. See the captions of Figures 5 and 7 for the definitions of
various contact fractions.
doi:10.1371/journal.pcbi.1002353.t001
Figure 5. Evolutions of various contact fractions of the NCBD/
ACTR complex at 475 K. All contact factions and helicities were
computed by averaging results from 50 independent unfolding
simulations. Qinter and QNCBD denote the native fractions of intermo-
lecular and NCBD tertiary intramolecular contacts, and aACTR and aNCBD
denote the overall helicities of ACTR and NCBD. Significant fluctuation
remains in the raw averaged contact fraction traces (grey traces), and
thus 50-ps running averages (dotted traces) are plotted for clarity. The
solid traces correspond to the best single exponential fits (see Table 1
for the fitted kinetic constants). Note that both Qinter and QNCBD quickly
decrease from above 0.8 to ,0.4 during the first 10–20 ps. The initial
decay is out of the plotting range and not shown for clarity.
doi:10.1371/journal.pcbi.1002353.g005
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Native and non-native salt-bridges in encounter
complexes and intermediates
One of the most notable features of the NCBD/ACTR complex
is a buried salt-bridge between NCBD R2105 and ACTR D1068
[91] (see Figure 1A), which is also conserved in the interaction of
NCBD with p53 TAD [92]. Interestingly, this buried salt-bridge is
part of a local network of salt-bridges that could form between
multiple complementary charges, including R2105 and K2108 of
NCBD and D1060, E1065, and D1068 of ACTR (see Figure 1A).
This network of native and non-native salt-bridges appears to play
a significant role in stabilizing the putative intermediate state,
either thermodynamically or kinetically. Although most individual
salt-bridges frequently break and reform during individual
unfolding simulations (see Figure S8), on average they largely
persist throughout the 10 ns unfolding simulations at 475 K and
hinder the transition from the partially bound intermediates to
fully disassociated ones (see Figure 8). Out of the 50 unfolding
simulations at 475 K, the complexes fully dissociate only by the
end of 10 ns simulations in six cases. The native salt-bridges,
between NCBD R2105 and ACTR D1068 and D1060, are the
most protected. As shown in Figure 8, they are the most preserved
and remain formed over 80% of the time throughout the
simulations (blue and black traces in Figure 8A). NCBD K2108
is adjacent to R2015 and close enough to interact with ACTR
D1068 and D1060, but these salt-bridges are more solvent-
exposed and thus slightly less preserved during high-temperature
simulations. The side chain of ACTR E1065 is positioned away
from NCBD in the native structure. Partial unfolding of Aa2
allows E1065 to rotate and participate in the salt-bridge network
with 10–30% probability by the end of the 10 ns simulation at
475 K (purple and red traces in Figure 8A).
The conformational heterogeneity of the intermediate state does
not permit reliable free energy calculations to quantify the
contribution of salt-bridge interactions to stability. Nonetheless,
previous mutagenesis studies have suggested that the buried salt-
bridge between NCBD R2105 and ACTR D1068 contributes
minimally to binding affinity [95]. The salt-bridge network likely
could not significantly stabilize the intermediate state thermody-
namically, either, which raises a concern that the observed
persistence of the local salt-bridge network is artificial, such as due
Figure 6. Free energy surfaces of (un)binding and (un)folding of the wild-type and mutant NCBD/ACTR complex. A. Computed from
the first 5 ns of 50 independent simulations of the wild-type NCBD/ACTR complex (WT) at 475 K. B. Computed from the first 5 ns of 50 independent
simulations of the double-Leu mutant complex (NCBD:R2105L/ACTR:D1068L; DM) at 450 K. Contours are drawn at every kT.
doi:10.1371/journal.pcbi.1002353.g006
Figure 7. Evolutions of the fractions of native intermolecular interactions of individual helices of the NCBD/ACTR complex. The grey
traces were calculated from averaging 50 unfolding simulations at 475 K and the colored traces are 50-ps running averages.
doi:10.1371/journal.pcbi.1002353.g007
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to over-stabilization of charge-charge interactions in the GBSW/
MS2 implicit solvent. To address this concern, we first examine
the potential of mean forces (PMFs) between Arg and Asp side
chain analogs in TIP3P and GBSW/MS2. The results, summa-
rized in Figure 8, show that GBSW/MS2 actually slightly under-
stabilizes the Arg-Asp interaction compared with TIP3P, either in
a constrained head-to-head configuration (which was used in the
force field optimization [72]) or when fully unconstrained. In
particular, configurationally unconstrained Arg-Asp interaction is
unstable in GBSW/MS2 (Figure 9B). Therefore, the observed
stabilization effects of salt-bridges on the intermediates are likely of
a kinetic nature. Such kinetic stabilization arises from substantial
desolvation barriers in disassociation of salt-bridges, particularly in
partially folded protein environments where the side chain
configurations are restricted (e.g., see Figure 9A). With a
concentrated local network of salt-bridges, very large desovaltion
barriers can be expected for complete dissociation of NCBD and
ACTR, which explains why only a small fraction of the high-
Figure 8. Native and non-native salt-bridges in the NCBD/ACTR interaction. A. Evolutions of average probabilities of various salt-bridge
interactions during unfolding simulations at 475 K. Arg and Glu/Asp residues were considered in contact if the carbonyl carbon and Arg CZ distance
was no greater than 5 A˚, and Lys and Glu/Asp residues were considered in contact if the side chain carbonyl carbon and amide nitrogen distance is
no greater than 4 A˚. B. Two representative final conformations after 10 ns simulations at 475 K. NCBD and ACTR are colored orange and gray,
respectively. The side chains of key charged residues are also shown, including NCBD R2105 and K2108 and ACTR D1060, E1065, and D1068. The
snapshot on the top represents a case where all six possible salt-bridges are formed, and the one at the bottom represents a case where only the
native ones, between NCBD R2105 and ACTR D1068 and D1060, are formed.
doi:10.1371/journal.pcbi.1002353.g008
Figure 9. Potential of mean forces of the Arg-Asp interactions in implicit and explicit solvents. All profiles were calculated using umbrella
sampling and WHAM (see Methods). The center-of-mass (CM) separation is used as the order parameter in the unconstrained PMF.
doi:10.1371/journal.pcbi.1002353.g009
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temperature simulations (6 out of 50) successfully reached the fully
unbound state in 10 ns.
To further confirm that the observed salt-bridge network is not
an artifact of implicit solvent, a set of 10 unfolding simulations was
performed in TIP3P explicit solvent at 500 K. Most simulations
were terminated between 3 to 4 ns when the complex size
exceeded the periodic box dimensions. The lengths of these
simulations are insufficient to capture degrees of unfolding and
unbinding similar to implicit solvent simulations, and the number
of trials is insufficient to obtain smooth curves for kinetic fitting.
Nonetheless, visual inspection of simulation trajectories as well as
examination of the evolution of various contact fractions support
an unbinding and unfolding mechanism that is consistent with the
one derived from implicit solvent simulations (see Figure S9). The
same set of native and non-native interactions, particularly the
buried one between NCBD R2105 and ACTR D1068 (blue trace
in Figure S9B), persist and appear to stabilize the partially
unbound and unfolded intermediates. Note that the helical
secondary structures are substantially over-stabilized in these
explicit solvent simulations (e.g., see the blue trace in Figure S9A).
This is a known artifact of the current version CHARMM22/
CMAP explicit solvent force field [78,109,110].
A double-Leu mutant complex follows a similar
unfolding and unbinding mechanism
A control simulation of the double-Leu mutant complex,
NCBD:R2105L/ACTR: D1068L, at 300 K suggests that the
native fold remains stable in the GBSW/MS2 implicit solvent
(data not shown). A set of 50 unfolding simulations was carried out
at 450 K to further investigate the role of the buried salt-bridge in
synergistic folding. The heterogeneity of the unfolding/unbinding
pathway observed in the wild-type complex (e.g., see Figure 5) is
even more pronounced without the buried salt-bridge. All
averaged time traces of contact fractions remain very noisy (e.g.,
see Figure S10). Most traces cannot be satisfactorily fitted to either
single or double exponential functions, preventing quantitative
analysis of unfolding and unbinding kinetics. Nonetheless, the
pseudo binding and folding free energy surface computed from the
first 5 ns of the unfolding trajectories appears to resemble that
from simulations of the wild-type complex (see Figure 6). In
particular, a similar intermediate state exists at Qinter,0.2 and
QNCBD,0.15; however, the small free energy barrier separating
the intermediate and fully unbound states in Figure 6A is largely
absent in Figure 6B. Removal of NCBD:R2105L largely disrupts
the local salt-bridge network. The intermediate state appears to
have much shorter resident times, and can quickly fluctuate to the
fully unbound state. Importantly, examination of the evolution of
intermolecular contact factions of individual NCBD and ACTR
helices, shown in Figure S10, supports that the mutant complex
largely follows a similar, albeit more heterogeneous, unbinding
and unfolding mechanism, with the N-terminal a1 helices
disassociated first (black traces in Figure S10B–C). These results
suggest the local salt-bridge network does not appear to
fundamentally modulate the recognition mechanism. Instead, it
mainly augments a productive synergistic folding mechanism
inherent in (the topology of) the NCBD/ACTR complex, by
transiently stabilizing a key on-pathway intermediate state to
facilitate complete folding en route to the specific complex.
Discussion
With one of the highest levels of residual structures, NCBD is an
intriguing model system for understanding the roles of residual
structure vs. conformational fluctuations in coupled binding and
folding of IDPs. We have combined equilibrium and non-
equilibrium simulations using physics-based, atomistic protein
force fields to characterize the conformational properties of
unbound NCBD and ACTR and to understand how these
properties facilitate efficient synergistic folding of these two IDPs.
The calculation recapitulates that free NCBD has folded-like
helical content, is strongly fluctuating, and samples a wide range of
tertiary configurations, which is consistent with the previous
notion that free NCBD is a molten globule [96]. Intriguingly, the
calculated disordered ensemble of NCBD contains significant
populations with helical packings that are highly similar to all
those previously observed experimentally in isolation and in
complex with various targets. Observations of such pre-folded
conformations, especially for IDPs with significant residual
structures like NCBD, could be considered strong evidence for
conformational selection-like mechanisms, where such preformed
structural elements provide initial binding sites. Direct examina-
tion of the unfolding and unbinding pathways in high-temperature
simulations, however, shows that both ACTR and NCBD tend to
unfold first before unbinding, suggesting an induced folding-like
baseline mechanism for their synergistic folding. This seemingly
surprising result appears to be consistent with the observation that,
although individual Ca1/Ca2 and Ca2/Ca3 helical pair samples
folded-like packing with substantial probability, these configura-
tions rarely occur simultaneously. Therefore, population of folded-
like tertiary conformations on the whole domain level is
insufficient to support conformational selection-like mechanisms
on the baseline level. Further analysis reveals an on-pathway
intermediate state that mainly involves the C-terminal helices of
ACTR and NCBD, which also has been predicted by a recent
coarse-grained simulation study using topology-based models [50].
Importantly, existence of such a major intermediate state also
appears to be consistent with a recent H/D-MS experiments
showing that peptide segments within the C-terminal regions of
NCBD and ACTR have much larger protection factors compared
with those mapped into other regions of the complex [106]. Our
kinetic analysis suggests that, once the initial mini folding core is
formed, the N-terminal helix of NCBD folds rapidly (Table 1),
allowing subsequent facile binding and folding the ACTR N-
terminal helix en route to the final specific complex. Therefore,
although the baseline mechanism is induced folding-like, confor-
mational selection actually occurs at local levels. Together with
our recent topology-based modeling study [50], the atomistic
simulations strongly support the prediction that synergistic folding
of NCBD and ACTR follows the ‘‘extended conformational
selection’’ mechanism [107]. Our topology-based modeling of the
NCBD/ACTR interaction [50] has revealed a separate, albeit less
prevalent, pathway where binding is initiated by the N-terminal a1
helices. These mechanistic insights on synergistic folding of NCBD
and ACTR, derived from the atomistic and coarse-grained
simulations, are summarized in Figure 10.
An intriguing interplay appears to exist among residual
structures, conformational fluctuations, and electrostatic interac-
tions to facilitate the rate-limiting step of forming the partially
folded intermediates. The NCBD Ca2/Ca3 helix-turn-helix motif
appear to be conformationally more restricted (Figure 2D),
whereas the C-terminus of Ca3 retains the least amount of helical
content and is considerably more heterogeneous (Figure S2B).
Both features were also observed in the previous NMR chemical
shift and relaxation analysis [96]. Such a balance of residual
structures and conformational fluctuations is likely important for
the NCBD C-terminal to act as a key initiation point for coupled
folding and binding to ACTR and other proteins. Another novel
insight provided by the current atomistic simulations is the role of
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a local network of native and non-native salt-bridges in transiently
stabilizing the intermediates. These salt-bridge interactions likely
do not contribute substantially to the thermodynamic stability of
either the intermediates or the final specific complex [95], but
substantial desolvation barriers involved in breaking up these
interactions in a conformationally restricted protein environment
(e.g., Figure 9A) can extend the resident time of the intermediates
to allow the rest of the complex to fold with higher efficiency. As
demonstrated using a dual-transition state kinetic model [59],
efficient folding upon encounter is necessary for achieving facile
binding at or near the diffusion-limited basal binding rate, a highly
desirable property for signaling and regulatory IDPs that need to
constantly evade protein degradation machinery in cell. IDPs are
known to be enriched with charges [6]. NCBD and ACTR are no
exceptions, with +6 and28 net charges, respectively (including the
flanking loops that remain disordered in the complex [91]). These
enriched charges hinder (independent) folding and can protest
against aggregation. In addition, long-range electrostatic interac-
tions between these large numbers of complementary charges on
NCBD and ACTR could dramatically enhance the encounter
rate, similar to electrostatic steering, which is known to be
important in interactions of globular protein [111]. Furthermore,
the complementary pattern of charge, especially within the
predicted mini folding core involving the C-termini (Figure 1),
suggests that long-range electrostatic interactions could further
promote folding-competent encounter complexes before transient-
ly stabilizing the on-pathway intermediates via formation of short-
range salt-bridge network. These effects can enhance the efficiency
of folding upon encounter to promote facile recognition.
The current study also reveals important limitations in both the
protein force field accuracy and sampling capability, especially for
modeling IDPs of moderate sizes and with complex residual
structures. These limitations underscore the importance of
continual development of the protein force field, with increased
focus on balancing various competing interactions to allow an
accurate description of not only a few (native) folds but also the
whole conformational equilibrium [82,112]. Sampling methodol-
ogies clearly need to improve. The standard temperature REX-
MD has failed to achieve convergence for the disordered ensemble
of NCBD within 100 ns. Besides limited simulation timescale,
certain limitations of the implicit solvent protein force field also
contributed. In particular, current empirical protein models have
been shown to contain a systematic bias to over-stabilize protein-
protein interactions [113,114]. Furthermore, simple surface area-
Figure 10. Overall mechanism of synergistic folding of NCBD and ACTR. The schematic view is based on the current atomistic simulations
as well as the previous coarse-grained modeling [50]. It illustrates that unbound ACTR is largely unstructured and NCBD has significant helical
structures. The nonspecific encounter complexes could evolve toward the bound state through two parallel pathways. The salt-bridge network that
plays a key role in stabilizing Intermediate I along the prevalent pathway is also illustrated.
doi:10.1371/journal.pcbi.1002353.g010
Synergistic Folding of Disordered Proteins
PLoS Computational Biology | www.ploscompbiol.org 11 January 2012 | Volume 8 | Issue 1 | e1002353
based estimation of the nonpolar solvation free energy employed
in most current implicit solvent models also tends to over-stabilize
nonspecific compact protein states [82]. The standard temperature
REX-MD clearly has limited ability to sample alternative deeply
trapped low energy states with high efficiency. These limitations
together have also prevented us from more directly investigating
the proposed mechanistic roles of electrostatic interactions using
atomistic simulations. Despite these outstanding limitations, the
key mechanistic features derived from atomistic physics-based
simulations, coarse-grained topology-based modeling, and various
biophysical measurements are remarkably consistent, which
suggests that an integration of multi-scale modeling and
experimentation can provide a viable approach for understanding
the functional and control of IDPs.
Methods
REX/GBSW simulations of free NCBD and ACTR
Only segments of the NCBD and ACTR domains that are
structured in the complex are included in the current simulations,
which include residues 2066–2112 for NCBD (in mouse CBP
numbering; SALQD LLRTL KSPSS PQQQQ QVLNI LKSNP
QLMAA FIKQR2105 TAKYV AN) and residues 1040–1086 for
the ACTR domain (in human ACTR numbering; E GQSDE
RALLD QLHTL LSNTD ATGLE EID1068RA LGIPE LVNQG
QALEP K). The peptide termini are neutralized using with either
acetyl (Ace) or amine (NH2) groups. A previously optimized
GBSW/MS2 model was used in all implicit solvent simulations
unless otherwise noted [72]. This model adopts an effective
approximation of the molecular surface for defining the solute-
solvent boundary, which is believed to be more physical compared
to the van der Waals-like surface used in the original GBSW
model [115,116]. Importantly, the GBSW/MS2 model has also
been carefully optimized to balance solvation and intramolecular
interactions and can reasonably capture the competition between
a and b secondary structures. Specifically for NCBD/ACTR, the
structure of the complex (PDB: 1kbh [91]) remains stable in the
GBSW/MS2 force field for over 100 ns, but substantially deviates
from the native conformation in the original GBSW protein force
field (see Figure S4).
REX was used to enhance the sampling of the accessible
conformational space of free NCBD and ACTR. For this, the
Multiscale Modeling Tools for Structural Biology (MMTSB)
toolset [117] (http://www.mmtsb.org) was used in conjunction
with CHARMM [118,119]. The basic idea of REX is to simulate
multiple non-interacting replicas at different temperatures simul-
taneously. Periodically, one attempts to exchange the simulation
temperatures between pairs of replicas based on a Metropolis
criterion derived from the detail balance principle. As such, not
only the resulting random walk in the temperature space facilitates
the system to cross the energy barriers and exploit the
conformational space more efficiently, but proper canonical
ensembles are also generated at all temperatures, allowing direct
calculation of thermodynamic properties for comparison with
experiments. We performed two independent REX simulations for
each peptide, initiated from the folded structure extracted from the
complex (control) and a fully extended conformation (folding),
respectively. Comparison of the calculated structure ensembles
from these independent control and folding runs with dramatically
different initial conditions allows rigorous assessment of the
convergence. In each REX simulation, 16 replicas were simulated
at temperatures exponentially distributed from 270 to 500 K.
SHAKE [120] was applied to fix the lengths of all hydrogen-
related bonds, allowing a 2.0 fs molecular dynamics (MD) time
step. Temperature exchanges between neighboring replicas were
attempted every 2 ps, and the total length of each REX simulation
was 100 ns (50,000 REX cycles). Similar REX/GBSW protocols
have proven effective in calculating the disordered structural
ensembles for other IDPs (albeit of smaller sizes than NCBD and
ACTR studied in the current work) [41,55]. All analysis was
performed based on the conformations sampled during the last
60 ns of the control simulation at 305 K (where most existing
experimental data were acquired), unless otherwise noted. The
orientations of helical segments (1044–1058, 1063–1071, 1072–
1080 in ACTR; 2067–2076, 2086–2091, 2095–2110 in NCBD)
were calculated using the Chothia-Levitt-Richardson algorithm
[121] as implemented in CHARMM. The K-means clustering
algorithm as implemented in the MMTSB toolset was used to
cluster the calculated disordered ensembles based on mutual Ca
RMSD distances. Various clustering radii ranging from 1.5 to
4.5 A˚ were tested before an optimal radius of 3.0 A˚ was used for
the final clustering results presented. All molecular visualizations
were generated using the VMD software [122].
Room temperature and high-temperature simulations of
the wild-type and mutant NCBD/ACTR complexes
The same peptide segments defined above were included the
simulations of the complex. The model 1 from the NMR ensemble
(PDB: 1kbh) was first equilibrated in the GBSW/MS2 implicit
solvent using energy minimization and short MD with weak
harmonic positional restraints imposed on all backbone heavy
atoms. Subsequently, a 160 ns unrestrained simulation was
performed at 300 K to examine the structural stability and
dynamics of the complex near its native basin. The native
structure of the NCBD:R2105L/ACTR:D1068L double-Leu
mutant complex was prepared by computational mutagenesis
and then equilibrated using a similar protocol as described above.
To identify the optimal temperatures for unbinding/unfolding
simulations, a series of pilot simulations was performed at
temperatures ranging from 350 K to 500 K (e.g., see Figure S5).
At the optimal temperature, the complex should unfold/unbind
within tractable time scales (e.g., 10–20 ns) while retaining
important details of the unfolding/unbinding pathways. Once
such optimal temperatures were chosen (450–475 K for the wild-
type and 450 K for the mutant), 50 independent high-temperature
simulations of 10–20 ns in length were initiated from the
equilibrated native structures with different initial velocities. The
results presented in this work are averages computed from 50
unfolding simulations unless otherwise noted. For native fraction
analysis, a list of native tertiary contacts (shown in Figure S6) was
first identified using the equilibrated native structure based on side
chain minimal heavy atom distances with a 4.2 A˚ cutoff. The
native contacts were then divided into inter-molecular and intra-
molecular categories. In analysis of the high-temperature simula-
tion trajectories, a contact was considered formed when the
minimal heavy atom distance between two side chains was no
greater than 4.5 A˚. Helicity of various helical segments was
calculated based on the hydrogen bonding patterns using the
COOR SECS module of CHARMM.
Explicit solvent high-temperature simulations
Additional high-temperature unfolding and unbinding simula-
tions of the wild-type complex were performed in TIP3P water to
examine the unfolding/unbinding pathway and in particular the
putative role of the buried salt-bridge between NCBD:R2105 and
ACTR:D1068 in (transiently) stabilizing the intermediate state(s).
For this, the equilibrated NCBD/ACTR complex was placed in a
cubic water box with periodic boundary conditions imposed. The
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final solvated system contains 9176 TIP3P water molecules and
the box size is ,65 A˚. Two potassium ions were added to
neutralize the total charge. The proteins were described by the
CHARMM22/CMAP protein force field [73–76]. The particle
mesh Ewald method was used for long-range electrostatic
interactions [123], and the van de Waals interactions were
smoothly switched off from 12 to 13 A˚. Lengths of all hydrogen-
related bonds were kept constant with SHAKE [120], and the MD
time step was 2 fs. After 10 ps of NPT equilibration at 300 K, a set
of 10 independent NVT productions was carried out at 500 K up
to 10 ns until the dimensions of the proteins exceed those of the
periodic box. The dynamic time step was reduced to 1 fs in the
NVT production simulations for numerical stability.
Free energy calculations
An umbrella sampling protocol [77] was used to compute the
PMFs between the side chains of Asp and Arg, either constrained
in a head-to-head configuration [77] (see Figure 9) or allowed to
freely rotate. In the constrained setup, the side chains were allowed
to move only in fixed orientations along the reaction coordinate
(indicated by a dashed line in Figure 9), enforced using the MMFP
module in CHARMM. For explicit solvent simulations, solutes
were solvated by either ,710 TIP3P waters in a rectangular box
(for the constrained PMF) or by ,1040 TIP3P waters in a
truncated octahedral box (for the unconstrained PMF). Periodic
boundary conditions were imposed. Non-bonded and other setups
are identical to those described above for explicit solvent high-
temperature simulations. Harmonic restraint potentials were
placed every 0.5 A˚ along the reaction coordinate with a force
constant of 5.0 kcal/mol/A˚2. For each umbrella-sampling win-
dow, the system was first equilibrated for 60 ps, followed by 2 ns
(constrained PMF) or 4 ns (unconstrained PMF) NPT production
at 300 K and 1 atm. The final PMFs were calculated using the
weighted histogram analysis method (WHAM) [124]. The
constrained PMF in GBSW/MS2 was computed by direct
translation of the side chains along the reaction coordinate, and
the unconstrained PMF in GBSW/MS2 was computed in the
same umbrella sampling protocol except that implicit solvent was
used instead of TIP3P waters. Convergence of the PMFs was
examined by comparing results from the first and second halves of
the data and was shown to be on the order of 0.2 kcal/mol.
Supporting Information
Figure S1 Convergence of the calculated residue helicity
of free NCBD. Residue helicities calculated using different
segments of the folding (A) and control (B) REX simulations are
shown. Only conformations sampled at 305 K were included in
the analysis.
(TIF)
Figure S2 Additional conformational properties of free
NCBD. A) Distributions of the radius of gyration, and B) Ca
RMSF profiles at 305 K, calculated from the last 60 ns of control
(red traces) and folding (black traces) simulations.
(TIF)
Figure S3 Orientations of NCBD Ca1 and Ca3 with
respect to Ca2. Conformations that belong to the six most
populated clusters of free NCBD sampled at 305 K are color-
coded. See the caption of Figure 3 in the main text for additional
information.
(TIF)
Figure S4 Summary of control simulations of theNCBD/
ACTR complex in GBSW and GBSW/MS2. A) Backbone
RMSD as a function of time. B) Number of helical residues as a
function of time. C) The Ca RMSF profiles computed from the last
50 ns of the 100 ns control simulations. Helical segments of ACTR
and NCBD are marked. D–E) The final snapshots overlaid with the
PDB structure (shown in gray cartoon). The results suggest that the
NCBD/ACTR complex is unstable in GBSW both at the secondary
and tertiary levels. In contrast, the complex remains reasonably
stable in GBSW/MS2, with significant fluctuations mainly observed
in the C-terminal segment of ACTR, and to a lesser extent in the
NCBD C-terminus (see panel C).
(TIF)
Figure S5 Trial unfolding simulations in GBSW/MS2 at
different temperatures. The numbers of helical residues of
NCBD and ACTR are monitored to detect the unbinding/
unfolding of the complex.
(TIF)
Figure S6 Tertiary contacts of the NCBD/ACTR com-
plex. The contacts were derived based on the first model of
PDB:1kbh. Residues are considered in contact if the minimal
heavy atom distance is no more than 4.2 A˚. The black bars
indicate the ranges of all helical segments in NCBD and ACTR.
Although there are a large number of intermolecular contacts (62;
black dots), there are only 11 (blue dots) and 19 (red dots) tertiary
intramolecular contacts for ACTR and NCBD, respectively.
(TIF)
Figure S7 Evolution of various contact fractions in
GBSW/MS2 simulations at 450 and 475 K. The grey traces
were calculated from averaging 50 independent simulations at
corresponding temperatures, and the colored traces are 50-ps
running averages.
(TIF)
Figure S8 Distances between key charged residues
during three representative unfolding simulations at
475 K. For Arg and Glu/Asp pairs, the distance between the side
chain carbonyl carbon and Arg CZ distance is shown. For Lys and
Glu/Asp pairs, the distance between the side chain carbonyl
carbon and amide nitrogen is shown.
(TIF)
Figure S9 Evolution of various contact fractions during
unfolding simulations in TIP3P at 500 K. All curves were
calculated from averaging 10 independent simulations of 3 to 4 ns
in length (only the first 3 ns are shown). The grey traces were
calculated from averaging 50 independent simulations, and the
colored traces are 50-ps running averages. The results are
consistent with key observations derived from GBSW/MS2
simulations. Specifically, 1) the baseline mechanism for coupled
binding and folding of NCBD is an induced folding-like one,
where binding precedes folding (Panel A); Specifically, fitting of
Qinter and QNCBD traces to single exponential functions yields half
times, t= 0.35 ns and 0.25 ns, respectively. 2) The C-terminal
segments initiate binding (thus the first helices unbind the first; see
black traces in Panels C–D); 3) the local native and non-native salt-
bridges persist in the partially unfolded and partially unbound
intermediate state (Panel B). Note that the helical secondary
structures appear to be over-stabilized (e.g., see the blue trace in
Panel A), which is a known artifact of the current version
CHARMM22/CMAP explicit solvent force field.
(TIF)
Figure S10 Evolution of various contact fractions during
unfolding simulations of the mutant NCBD/ACTR com-
plex at 450 K. The grey traces were calculated from averaging 50
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independent simulations, and the colored traces are 50-ps running
averages. The simulations were 15 ns in length. The complex
unfolds rapidly and thus only results from the first 5 ns are shown.
(TIF)
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